We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIVB icon
2301
Civista Bancshares
CIVB
$597M
$157K ﹤0.01%
7,109
CGEM icon
2302
Cullinan Oncology
CGEM
$1.26B
$157K ﹤0.01%
6,098
OLMA icon
2303
Olema Pharmaceuticals
OLMA
$913M
$157K ﹤0.01%
5,611
CMBM
2304
DELISTED
Cambium Networks
CMBM
$157K ﹤0.01%
3,242
SNR
2305
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$156K ﹤0.01%
17,817
-17,066
-49% -$117K
MBIN icon
2306
Merchants Bancorp
MBIN
$2.52B
$156K ﹤0.01%
5,967
RCKY icon
2307
Rocky Brands
RCKY
$356M
$156K ﹤0.01%
2,801
CCNE icon
2308
CNB Financial Corp
CCNE
$1.03B
$155K ﹤0.01%
6,782
GOLD
2309
Gold.com Inc
GOLD
$1.3B
$155K ﹤0.01%
+6,654
New +$149K
KNSA icon
2310
Kiniksa Pharmaceuticals
KNSA
$6.1B
$154K ﹤0.01%
11,087
ICAD
2311
DELISTED
iCAD Inc
ICAD
$154K ﹤0.01%
8,918
SPRU icon
2312
Spruce Power Holding Corp
SPRU
$38.9M
$154K ﹤0.01%
+2,312
New +$136K
FBRX icon
2313
Forte Biosciences
FBRX
$1.57B
$154K ﹤0.01%
+183
New +$165K
EVC icon
2314
Entravision Communication
EVC
$832M
$154K ﹤0.01%
+22,980
New +$104K
NVEC icon
2315
NVE Corp
NVEC
$591M
$153K ﹤0.01%
2,070
ONEW icon
2316
OneWater Marine
ONEW
$204M
$153K ﹤0.01%
3,644
SSTI icon
2317
SoundThinking
SSTI
$106M
$153K ﹤0.01%
+3,138
New +$120K
FFIC
2318
DELISTED
Flushing Financial
FFIC
$151K ﹤0.01%
7,057
-5,426
-43% -$123K
RNAC icon
2319
Cartesian Therapeutics
RNAC
$263M
$151K ﹤0.01%
+1,205
New +$143K
HTBK
2320
DELISTED
Heritage Commerce
HTBK
$151K ﹤0.01%
13,524
-10,346
-43% -$123K
CUE icon
2321
Cue Biopharma
CUE
$128M
$150K ﹤0.01%
430
EGLE
2322
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$150K ﹤0.01%
+3,177
New +$144K
GRTS
2323
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$150K ﹤0.01%
16,454
+12,198
+287% +$113K
TNXP icon
2324
Tonix Pharmaceuticals
TNXP
$205M
0
UFCS icon
2325
United Fire Group
UFCS
$1.37B
$149K ﹤0.01%
5,380
-4,297
-44% -$134K

Similar funds

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.